Načítá se...
Role of FXR in Liver Inflammation during Nonalcoholic Steatohepatitis
PURPOSE OF REVIEW: About 15–25% of patients with simple steatosis of non-alcoholic fatty liver disease progresses to non-alcoholic steatohepatitis (NASH), and the underlying mechanism for this progression has not been elucidated. NASH ultimately could progress to cirrhosis, an irreversible condition...
Uloženo v:
| Vydáno v: | Curr Pharmacol Rep |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5624538/ https://ncbi.nlm.nih.gov/pubmed/28983452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40495-017-0085-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|